From Medscape Rheumatology

Coverage from the

13th International Congress on Spondyloarthritides (ICS 2022)

September 07 - 09, 2022; Ghent, Belgium

September 07 - 09, 2022 Ghent, Belgium

Conference News

ICS 2022 Undiagnosed SpA Common in Chiropractor Back Pain Referrals
MDedge News, September 20, 2022
ICS 2022 ASDAS Measurement of SpA Activity Not Influenced by Gender
MDedge News, September 14, 2022
ICS 2022 Filgotinib Reduces Flare Risk in Uveitis in Phase 2 Study
MDedge News, September 13, 2022

ICS 2022 Limited Role for COX-2, TNFi in Reducing AxSpA Progression
MDedge News, September 12, 2022
ICS 2022 Bimekizumab Effective for AxSpA Regardless of Prior TNFi Use
MDedge News, September 9, 2022
ICS 2022 AI Detects Erosions, Ankylosis in Patients With Sacroiliitis
MDedge News, September 9, 2022

Medscape Rheumatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from ICS 2021

Real-World Data Generate Debate on Definition of Axial SpA Flare Changes in the Bath Ankylosing Spondyloarthritis Disease Activity Index could be used to monitor patient-reported flares in axial spondyloarthritis.
Medscape Medical News, Sep 23, 2021
csDMARDs Could Add to TNF Inhibitors' Benefits in SpA EuroSpA Research Collaboration data hint at better retention and remission rates with csDMARD-TNFi cotherapy vs TNFi alone in spondyloarthritis.
Medscape Medical News, Sep 16, 2021
csDMARDs Could Add to TNF Inhibitors' Benefits in SpA EuroSpA Research Collaboration data hint at better retention and remission rates with csDMARD-TNFi cotherapy vs TNFi alone in spondyloarthritis.
Medscape Medical News, Sep 16, 2021

Previous Coverage

Related Resources

Spine